➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

ZALTRAP Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: ZALTRAP

Patents:	11
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for ZALTRAP

Recent Clinical Trials for ZALTRAP

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Tanta University	Phase 1/Phase 2
Amin El Sayed Nawar	Phase 1/Phase 2
Kapil Kapoor	Phase 2

See all ZALTRAP clinical trials

Patent Text Search: US Patents for ZALTRAP

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	The Rockefeller University (New York, NY)	2032-10-31	RX		search
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	HANGZHOU DAC BIOTECH CO., LTD. (Hangzhou, CN)	2035-07-15	RX		search
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS (GR)	2035-07-08	RX		search
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	HANGZHOU DAC BIOTECH CO., LTD. (Hangzhou, CN)	2035-07-15	RX		search
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	SANOFI (Paris, FR)	2034-07-18	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for ZALTRAP

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Israel	250905	Start Trial
China	107076750	Start Trial
European Patent Office	3375440	Start Trial
Australia	2015289124	Start Trial
Hong Kong	1215000	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Harvard Business School

Moodys

Boehringer Ingelheim

Medtronic

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.